Showing 971-980 of 987 results for "".
- Allergan CEO Calls for Consensus on Medical Aesthetic Treatment in Minorshttps://modernaesthetics.com/news/allergan-ceo-calls-for-consensus-on-medical-aesthetic-treatment-in-minors/2472213/Allergan Chairman & CEO Brent Saunders, the father of two high school-aged girls, is speaking up and out about the risks associated with offering medical aesthetic treatments to minors. In a new blog post, he writes “we must remember that anyone under the age of 18 is still matu
- Survey: Many Bothered By Double Chins, Take Steps To Cover Uphttps://modernaesthetics.com/news/survey-many-bothered-by-double-chins-take-steps-to-cover-up/2472259/Close to 50 percent of individuals are bothered by the appearance of the area under their chin, and many alter their behavior as a result, according to a new survey commissioned by Allergan plc.<
- Allergan Agrees to Acquire ZELTIQ for $2.47 Billionhttps://modernaesthetics.com/news/allergan-agrees-to-acquire-zeltiq-for-247-billion/2472280/Allergan plc and ZELTIQ® Aesthetics, Inc. have entered into a definitive agreement under which Allergan has agreed to acquire ZELTIQ for $56.50 per share, or $2.475 billion, subject to customary
- Allergan Launches Juvéderm Volitehttps://modernaesthetics.com/news/allergan-launches-juvderm-volite/2472287/Allergan plc launched Juvéderm Volite, an injectable product specifically designed to improve skin quality and last up to nine months with just one treatment session. This innovative new Allergan product uses the unique patented Vycross technology. The new HA injectable treatment d
- Update: Revance Starts Phase III Studies on RT002 for Frown Lineshttps://modernaesthetics.com/news/revance-starts-phase-iii-studies-on-rt002-for-frown-lines/2472297/Revance Therapeutics began two double-blind, placebo-controlled, North American Phase III trials to evaluate single injections of DaxibotulinumtoxinA (RT002) for the treatment glabellar lines in about 600 total patients. These pivotal trials
- Robin Unger, MDhttps://modernaesthetics.com/profiles/robin-unger-md/Lze24l/
- Contributing Editorhttps://modernaesthetics.com/profiles/contributing-editor/7rB8NP/
- Karan Lal, DO, MS, FAADhttps://modernaesthetics.com/profiles/karan-lal-do-ms-faad/L2YXnB/Originally from New York City, he grew up in Queens and attended Hunter Science High School in Manhattan. He graduated summa cum laude from the New York Institute of Technology, where he completed a rigorous seven-year accelerated combined medical program. He was selected to be an academic medical …
- Jeanette Blackhttps://modernaesthetics.com/profiles/jeanette-black/7vZak7/Tulane Univ SOM
- Madison Dini, JDhttps://modernaesthetics.com/profiles/madison-dini-jd/jmxpRw/Madison Dini is the Houston managing partner of Michelman & Robinson, LLP, an international law firm headquartered in Los Angeles, with additional offices in Irvine, San Francisco, Dallas, Chicago, New York, and London. She represents medical aesthetics companies and individuals as outside general …